TheraCryf PLC (TCF)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.80p
Buy
0.90p
0.00p (+0.00%)
Prices updated at 02 Jul 2024, 15:30 BST
| Prices minimum 15 mins delay
Prices in GBX
Evgen Pharma PLC is a clinical stage drug development company focused on cancer and neurological disease. Its pipeline is based on Sulforadex technology which includes synthetic and stabilized analogues of sulforaphane.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
0.85
0.00 (+0.00%)
Today open
0.85
0.00 (+0.00%)
Today, 15:30:50 BST
0.85
0.82p - 0.80p | |
3.40p - 0.60p | |
- | |
3.63m | |
- | |
75,000 | |
510,000 | |
1.55 | |
914,354.42 | |
1.79 | |
274.89m | |
GB00BSVYN304 | |
-0.01 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.